# The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration

> **NCT00227357** · — · COMPLETED · sponsor: **Ruth M. Rothstein CORE Center** · enrollment: 101 (actual)

## Conditions studied

- HIV Infections
- AIDS
- Opiate Dependence
- Post-Traumatic Stress Disorders

## Interventions

- **DRUG:** On-site - buprenorphine/naloxone (Suboxone)
- **DRUG:** Off-site - methadone or no agonist

## Key facts

- **NCT ID:** NCT00227357
- **Lead sponsor:** Ruth M. Rothstein CORE Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2010-06-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00227357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00227357, "The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00227357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*